Nawsherwan Mohammad: Exploring Thrombophilia in 2026
Nawsherwan Mohammad, Consultant Hematopathologist at Nanakaly Hospital, shared a post on LinkedIn:
“Thrombophilia in 2026
The modern approach to thrombophilia emphasizes precision medicine, recommending selective testing only when the results are likely to influence clinical management.
Testing is appropriate for patients with unprovoked or recurrent VTE, thrombosis at unusual sites, recurrent pregnancy loss, a strong family history, or suspected antiphospholipid syndrome, while it is generally not recommended for provoked VTE, during acute thrombosis or anticoagulation, or as routine screening of relatives.
Current evaluation focuses on high-yield tests, including Factor V Leiden, Prothrombin G20210A, antithrombin, protein C and protein S deficiencies, and antiphospholipid antibodies.
Treatment decisions should be based primarily on the patient’s clinical risk rather than thrombophilia status alone.
High-risk thrombophilias often require specialist care and extended anticoagulation, while emerging evidence supports the use of DOACs in selected patients.
Special populations, particularly pregnant women and patients with antithrombin deficiency, require individualized risk assessment and multidisciplinary management.
Overall, thrombophilia testing should be purpose-driven, evidence-based, and tailored to improve patient outcomes rather than performed routinely.”
Stay updated with Hemosyasis Today.
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE
-
Oct 12, 2026, 20:43Jazlyn A Selvasingh: Excited to Share Our Research at AAO-HNSF 2026 in Los Angeles
-
Oct 12, 2026, 20:31Natalia Kovtun: Higher Ferritin Cutoffs Now Define Iron Deficiency
-
Oct 12, 2026, 19:39Edward Loftus: Using Low-Dose Aspirin in Pregnant Women With IBD
-
Oct 12, 2026, 19:32Shruti Sachdeva: Strengthening the Fight against Anemia